Inovio Pharmaceuticals, Inc. (INO) vs Nautilus Biotechnology, Inc. (NAUT)

Inovio Pharmaceuticals, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and Nautilus Biotechnology, Inc. are of similar size ($126.9M and $126.1M). Across the 10 metrics below, Nautilus Biotechnology, Inc. leads on 6 and Inovio Pharmaceuticals, Inc. on 4.

Valuation

Metric INO NAUT Biotechnology median
P/E n/m n/m 7.88
P/S 249.64 n/m 11.47
P/B 22.03 0.94 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 183.59 n/m 10.73
Earnings yield (77.12%) (46.39%) (28.84%)
Free cash flow yield (83.14%) (42.05%) (23.03%)

Profitability

Metric INO NAUT Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) (36.21%) (57.72%)
Return on assets (114.64%) (30.00%) (49.22%)
Return on invested capital 0.00% (83.32%) 0.00%

Growth

Metric INO NAUT Biotechnology median
Revenue growth (TTM) (54.82%) — 5.64%
EPS growth (last fiscal year) 54.18% 16.07% —
Revenue growth, 5-year CAGR (61.18%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO NAUT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 10.14 4.73
Net debt to EBITDA 0.70 1.67 0.96

Dividend

Metric INO NAUT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric INO NAUT Biotechnology median
Market cap 126.89m 126.05m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack